PTEN and urinary bladder cancer: (47) identified exosomal long non-coding RNA PTENP1 as a potential biomarker for bladder cancer, demonstrating that it is downregulated in cancer tissues and plasma exosomes, and that it can suppress bladder cancer progression by competitively binding to microRNA-17 and modulating PTEN expression.